Folic acid functionalized gadolinium-doped carbon dots as fluorescence / magnetic resonance imaging contrast agent for targeted imaging of liver cancer. 2023

Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China.

Gadolinium-doped carbon dots (Gd-CDs), as a new class of nanomaterial, has a wide application prospect in targeted imaging and monitoring diagnosis and treatment of liver cancer because of their good fluorescence (FL)-magnetic resonance (MR) imaging properties. First, Gd-CDs were synthesized by hydrothermal method with gadodiamide as gadolinium source, citric acid as carbon source and silane coupling agent (KH-792) as coupling agent with FL quantum yield (QY) of 48.2%. Then, folic acid (FA), which is highly expressed in liver cancer, was used as a targeting component to modify Gd-CDs to obtain targeted imaging agent (Gd-CDs-FA). The results showed that Gd-CDs and Gd-CDs-FA have low cytotoxicity and good biocompatibility, and the targeting and selectivity of Gd-CDs-FA to HepG2 cells could be observed under confocal laser scanning microscope (CLSM). The T1 longitudinal relaxation rates (r1) of Gd-CDs and Gd-CDs-FA are 15.92 mM-1s-1 and 13.56 mM-1s-1, respectively. They showed good MR imaging ability in vitro and in vivo, and MR imaging in nude mice further proved the targeting imaging performance of Gd-CDs-FA. Therefore, Gd-CDs-FA with higher QY showed good FL-MR targeting imaging ability of liver cancer, which broke through the limitations of single molecular imaging probe in sensitivity and soft tissue resolution. This study provides a new idea for the application of Gd-CDs in FL and MR targeting imaging of liver cancer.

UI MeSH Term Description Entries

Related Publications

Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
December 2016, Journal of materials chemistry. B,
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
September 2014, Journal of materials chemistry. B,
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
December 2016, Biomacromolecules,
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
February 2011, Biomaterials,
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
May 2020, Magnetic resonance imaging,
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
March 2017, Biomaterials,
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
October 2015, Dalton transactions (Cambridge, England : 2003),
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
July 2015, Nanotechnology,
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
July 2019, Mikrochimica acta,
Jinglei Du, and Shizhao Zhou, and Yihua Ma, and Yingying Wei, and Qiang Li, and Hui Huang, and Lin Chen, and Yongzhen Yang, and Shiping Yu
January 1995, Journal of magnetic resonance imaging : JMRI,
Copied contents to your clipboard!